Top Markets
#1 TENDIES TENDIES +60.57%
#2 Threshold Network Threshold Network +53.84%
#3 Cash Cat Cash Cat +23.29%
#4 OSK OSK +16.15%
#5 Falcon Finance Falcon Finance +14.06%
#6 Magma Finance Magma Finance +13.46%
#7 Kite Kite +12.68%
#8 Ape and Pepe Ape and Pepe +12.62%
#9 Maple Finance Maple Finance +12.49%
#10 Kinetiq Kinetiq +10.94%
Coin of the day
TENDIES TENDIES
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Rang in aandelen #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Aandeelprijs
$0.8799
Laatst gesynchroniseerd: 2026-09-01
Marktkapitalisatie
$259.22M
Verandering (1 dag)
-7.85%
Verandering (1 jaar)
-14.57%
Land
US
Handel Invivyd, Inc. (IVVD)

Categorie

Healthcare
Koersgeschiedenis voor Invivyd, Inc. (IVVD)
Hoogste slotkoers: $0.88 op 2026-09-01

Laagste slotkoers: $27.68 op 2021-08-01
Koersgeschiedenis van Invivyd, Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -37.39%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.36 37.99%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.97%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $155.59 543.18%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $762.65 8.90%
CH